As Rare Disease Day 2026 shines a spotlight on patients [...]

ViiV Healthcare, the global specialist HIV company majority owned by [...]

Young adults in wealthy countries are four times more likely [...]

A new study confirms that Theranica’s Nerivio REN wearable for [...]

SolasCure has reported positive phase 2 data for Aurase Wound [...]

AC Immune has initiated a Phase 1 trial of its [...]

Fennec Pharmaceuticals has presented real world data supporting the integration [...]

Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

Abivax has presented new preclinical and clinical data for obefazimod [...]

Long-term VIVID-2 data show more than 90% of patients with [...]